Loading...
Targeting retinoblastoma protein phosphorylation in combination with EGFR inhibition in pancreatic cancer cells
Pancreatic ductal adenocarcinoma (PDAC) remains a particularly lethal disease that is resistant to targeted therapies. Tyrosine kinase inhibitors (TKIs), including erlotinib and gefitinib, which block the action of the human epidermal growth factor receptor type 1 receptor, provide small increases i...
Na minha lista:
| Udgivet i: | Int J Oncol |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
D.A. Spandidos
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6317693/ https://ncbi.nlm.nih.gov/pubmed/30535494 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijo.2018.4658 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|